期刊文献+

百合固金汤含药血清对巨噬细胞表面模式识别受体的影响 被引量:5

Effects of Bai He Gu Jin Tang Drug-serum on expression of PRR in macrophages
下载PDF
导出
摘要 目的观察传统抗痨方剂百合固金汤含药血清对巨噬细胞表面模式识别受体的影响,以探讨传统医药抗结核的可能作用机制。方法按常规方法制备百合固金汤含药兔血清。以含药血清作用U937单核巨噬细胞24 h后,分别采用RT-PCR法和流式细胞仪检测巨噬细胞表面CR1、CR3、CD14、CD43、TLR2及TLR4的表达。同时设空白兔血清为对照。结果 RT-PCR和流式细胞仪结果均显示百合固金汤含药血清可使巨噬细胞表面模式识别受体CR1、CD14、TLR2、TLR4表达显著增高(P<0.05);而CR3仅在蛋白表达水平显示差异(P<0.05);CD43表达则未见显著差异(P>0.05)。结论传统抗痨方剂百合固金汤的抗结核作用可能通过对巨噬细胞表面模式识别受体的调节而发挥作用。 To investigate the effects of Bai He Gu Jin Tang Drug-serum on expression of pattern recognition receptor (PRR) in macrophages for evaluating the possible mechanism of Bai He Gu Jin Tang Drug against tuberculosis. We prepared the Bai He Gu Jin Tang Drug-serum and blank serum. The two serum samples were used to incubate with U937 monocyte-derived macrophages for 24 hours. Then, RT-PCR and FACS were used to detect the mRNA expression of CR1, CR3, CDI4, CD43, TLR2 and TLR4 in macrophages. Compared to blank serum group, the Bai He Gu Jin Tang drug-serum group significantly increased the mRNA and protein expressions of CR1, CD14, TLR2 and TLR4 in macrophages (P 〈 0.05), and up-regulated the CR3 protein expression (P 〈 0.05) while its mRNA expression didn't change. But the expression of CD43 protein and mRNA were no significant differences between the two goups (P〉0.05). All the results come to the conclusion that Bai He Gu Jin Tang maybe treat the tuberculosis by regulating these PRRs in macrophages.
作者 王莉新 王易
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第2期148-151,共4页 Immunological Journal
基金 上海市教委高校高水平特色发展项目(沪教委财2005 81号) 上海市教委重点学科(第五期 J50301)
关键词 百合固金汤 巨噬细胞 模式识别受体 Bai He Gu Jin Tang Macrophages Pattern-recognition receptor
  • 相关文献

参考文献11

  • 1张立兴.中国结核病控制工作面临的挑战[J].中华流行病学杂志,2004,25(8):645-646. 被引量:42
  • 2王莉新,王易.Toll样受体与结核分枝杆菌[J].现代免疫学,2008,28(5):429-432. 被引量:8
  • 3田代真一.和汉药の实验的研究における诸问题-invitmg实验の问题[J].和汉医药学会志,1991,8:218.
  • 4王力倩,李仪奎,符胜光,付惠娣.血清药理学方法研究探索[J].中药药理与临床,1997,13(3):29-31. 被引量:119
  • 5王晓蕾,雷建强,王洪海.巨噬细胞摄取结核分支杆菌相关的受体[J].中华结核和呼吸杂志,2003,26(5):297-299. 被引量:3
  • 6Doherty TM, Arditi M. TB, or not TB: that is the questiondoes TLR signaling hold the answer? [J]. J Clin Invest, 2004, 114 (2): 1699- 1703.
  • 7Schorey JS, Carroll MC, Brown EJ. A macrophage invasion mechanism of pathogenic mycohacteria [J]. Science, 1997, 277 (5329): 1091-1093.
  • 8Stenger S, Modlin RL. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors [J]. Curr Opin hnmunol, 2002, 14(4): 452-457.
  • 9Pompei L, Jang S, Zamlynny B, et al. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tubereulosis is due to use of distinct TLRs [J]. J Immunol, 2007, 178 (8): 5192-5199.
  • 10Drennan MB, Nicolle D, Quesniaux V J, et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection[J]. Am J Pathol, 2004, 164(1): 49- 57.

二级参考文献28

  • 1[1]Stewart GR,Wilkinson KA,Newton SM,et al.Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis[J].Infec Immun,2005,73:6831-6837.
  • 2[2]Gilleron M,Nigou J,Nicolle D,et al.The acylation state of myeobacterial lipomannans modulates innate immunity response through Toll-like receptor 2[J].Chem Biol,2006,13:39-47.
  • 3[3]Drennan MB,Nicolle D,Quesniaux VJ,et al.Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection[J].Am J Pathol,2004,164:49-57.
  • 4[4]Sweet L,Schorey JS.Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2-and MyD88-dependent manner[J].Biology,2006,80:415-423.
  • 5[5]Pompei L,Jang S,Zamlynny B,et al.Disparity in IL-12 release in dendritic cells and macrophages in response to My cobacterium tuberculosis is due to use of distinct TLRs[J].J Immunol,2007,178:5192-5199.
  • 6[6]Gandotra S,Jang S,Murray PJ,et al.Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis[J].Infect Immun,2007,75:5127-5134.
  • 7[7]Branger J,Leemans JC,Florquin S,et al.Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice[J].Int Immunol,2004,16:509-516.
  • 8[8]Bafica A,Scanga CA,Feng CG,et al.TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis[J].J Exp Med,2005,202:1715-1724.
  • 9[9]Sugawara I,Yamada H,Li C,et al.Mycobacterial infection in TLR2 and TLR6 knockout mice[J].Microbiol Immunol,20035 47:327-336.
  • 10[10]Pecora ND,Gehring AJ,Canaday DH,et al.Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function[J].J Immunol,2006,177:422-429.

共引文献168

同被引文献95

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部